Lv42
671 积分 2021-05-10 加入
Exploring the next generation of antibody-drug conjugates
1小时前
待确认
Antibody-drug conjugates for cancer therapy
1小时前
已完结
Optimal two-stage designs for phase II clinical trials
3小时前
已完结
Admissible two-stage designs for phase II cancer clinical trials
3小时前
待确认
HER2CLIMB-05: A Phase 3 Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-line Maintenance Therapy for HER2+ Metastatic Breast Cancer
1个月前
已关闭
Prognostic Factors and Survival Analysis after Radical Surgery in Elderly Patients with Colorectal Cancer Based on SEER Database
1个月前
已完结
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
2个月前
已完结
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
2个月前
已完结
CD44 in cancer
2个月前
已完结
Expert opinions on the technical guiding principles for clinical trials of drugs in the treatment of chronic hepatitis B virus infection
2个月前
已完结
皖公网安备34019202002308
